Acute heart failure – The ‘real’ Malaysian experience: An observational study from a single non-cardiac centre

Background: Cardiovascular care in Malaysia adopts a ‘spoke-and-hub’ model, leaving the majority of acute heart failure (AHF) care to non-cardiac centres. Granular data on AHF care are essential and yet remain scarce. Objectives: This study aimed to illustrate the baseline characteristics, managemen...

Full description

Bibliographic Details
Main Authors: Borhan, M.K (Author), Kasim, S. (Author), Raja Shariff, R.E (Author), Yusoff, M.R (Author)
Format: Article
Language:English
Published: SAGE Publications Inc. 2021
Series:Proceedings of Singapore Healthcare
Subjects:
Online Access:View Fulltext in Publisher
View in Scopus
LEADER 05873nam a2201333Ia 4500
001 10.1177-2010105820978664
008 220121s2021 CNT 000 0 und d
020 |a 20101058 (ISSN) 
245 1 0 |a Acute heart failure – The ‘real’ Malaysian experience: An observational study from a single non-cardiac centre 
260 0 |b SAGE Publications Inc.  |c 2021 
490 1 |a Proceedings of Singapore Healthcare 
650 0 4 |a acetylsalicylic acid 
650 0 4 |a acute heart failure 
650 0 4 |a Acute heart failure 
650 0 4 |a adult 
650 0 4 |a aged 
650 0 4 |a angiotensin receptor antagonist 
650 0 4 |a anticoagulant agent 
650 0 4 |a Article 
650 0 4 |a artificial ventilation 
650 0 4 |a ascites 
650 0 4 |a atrial fibrillation 
650 0 4 |a beta adrenergic receptor blocking agent 
650 0 4 |a blood cell count 
650 0 4 |a cardiomyopathy 
650 0 4 |a central venous pressure 
650 0 4 |a cerebrovascular accident 
650 0 4 |a cholesterol blood level 
650 0 4 |a chronic kidney failure 
650 0 4 |a chronic obstructive lung disease 
650 0 4 |a clopidogrel 
650 0 4 |a cohort analysis 
650 0 4 |a coronary artery disease 
650 0 4 |a crackle 
650 0 4 |a creatinine 
650 0 4 |a cross-sectional study 
650 0 4 |a diabetes mellitus 
650 0 4 |a dialysis 
650 0 4 |a digoxin 
650 0 4 |a dipeptidyl carboxypeptidase 
650 0 4 |a diuretic agent 
650 0 4 |a dopamine 
650 0 4 |a dyslipidemia 
650 0 4 |a dyspnea 
650 0 4 |a echocardiography 
650 0 4 |a electrocardiogram 
650 0 4 |a enkephalinase inhibitor 
650 0 4 |a epidemiology 
650 0 4 |a estimated glomerular filtration rate 
650 0 4 |a fatigue 
650 0 4 |a female 
650 0 4 |a furosemide 
650 0 4 |a glucose level 
650 0 4 |a glyceryl trinitrate 
650 0 4 |a heart arrhythmia 
650 0 4 |a heart block 
650 0 4 |a heart failure 
650 0 4 |a heart function test 
650 0 4 |a heart infarction 
650 0 4 |a heart left ventricle ejection fraction 
650 0 4 |a heart rate 
650 0 4 |a hemoglobin 
650 0 4 |a high density lipoprotein 
650 0 4 |a human 
650 0 4 |a hydroxymethylglutaryl coenzyme A reductase inhibitor 
650 0 4 |a hypertension 
650 0 4 |a hypertensive agent 
650 0 4 |a hypertensive factor 
650 0 4 |a hypervolemia 
650 0 4 |a intubation 
650 0 4 |a ischemia 
650 0 4 |a ischemic heart disease 
650 0 4 |a ivabradine 
650 0 4 |a leukocyte count 
650 0 4 |a limb swelling 
650 0 4 |a lipid fingerprinting 
650 0 4 |a low density lipoprotein 
650 0 4 |a lung congestion 
650 0 4 |a lung edema 
650 0 4 |a major clinical study 
650 0 4 |a male 
650 0 4 |a mean corpuscular volume 
650 0 4 |a middle aged 
650 0 4 |a mortality rate 
650 0 4 |a nitrate 
650 0 4 |a noninvasive ventilation 
650 0 4 |a noradrenalin 
650 0 4 |a observational study 
650 0 4 |a paroxysmal nocturnal dyspnea 
650 0 4 |a percutaneous coronary intervention 
650 0 4 |a potassium 
650 0 4 |a renal replacement therapy 
650 0 4 |a retrospective study 
650 0 4 |a rheumatic heart disease 
650 0 4 |a risk factor 
650 0 4 |a sodium 
650 0 4 |a stress test 
650 0 4 |a systolic blood pressure 
650 0 4 |a thiazide diuretic agent 
650 0 4 |a thorax pain 
650 0 4 |a thrombocyte 
650 0 4 |a triacylglycerol 
650 0 4 |a ultrafiltration 
650 0 4 |a urea 
650 0 4 |a valvular heart disease 
650 0 4 |a warfarin 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1177/2010105820978664 
856 |z View in Scopus  |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097417170&doi=10.1177%2f2010105820978664&partnerID=40&md5=ccf131d5b252775053664dc1caee608f 
520 3 |a Background: Cardiovascular care in Malaysia adopts a ‘spoke-and-hub’ model, leaving the majority of acute heart failure (AHF) care to non-cardiac centres. Granular data on AHF care are essential and yet remain scarce. Objectives: This study aimed to illustrate the baseline characteristics, management and outcome of AHF patients. Methods: A retrospective, cross-sectional study was conducted on 1307 AHF patients admitted between 1 January 2012 and 31 December 2016. Results: The younger and Malay-predominant population reflects the distribution of ischaemic heart disease in Malaysia, highlighting the need to tackle metabolic risks factors. The majority are precipitated by ischaemia (61.8%). Common co-morbidities include hypertension (70.9%), coronary artery disease (57.8%) and diabetes (62.2%). The majority were of New York Heart Association Class II (31.9%) and Class III (25.6%). A total of 14.5% required inotropes and vasopressors, 12.9% required intravenous nitrates and 8.6% required dialysis. A further 4.9% of patients required intubation and mechanical ventilation, and 25.9% required non-invasive ventilation. Readmission and mortality were extremely high in our population. Short inpatient stays, restricting optimisation of medication, and gaps in the provision of coronary intervention and stress testing are possible contributing factors. When compared to global and regional registries, disparities were noted specifically surrounding mortality rate and optimum use of guideline-directed medical therapy. Conclusion: Although smaller and single centred, our study provides a unique insight into a pure Malaysian-only cohort from a hospital with no cardiology services in-house, which is more reflective of the majority of hospitals in Malaysia, unlike previous studies and registries. © The Author(s) 2020. 
700 1 0 |a Borhan, M.K.  |e author 
700 1 0 |a Kasim, S.  |e author 
700 1 0 |a Raja Shariff, R.E.  |e author 
700 1 0 |a Yusoff, M.R.  |e author 
773 |t Proceedings of Singapore Healthcare